Clinical trial
Evaluation of the Alife Hera System as an Adjunctive Tool for the Prioritization of Embryos Deemed Suitable for Transfer: A Randomized Controlled Study
NCT05483985 is registered in ClinicalTrials.gov with Alife Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Alife Hera System as an Adjunctive Tool for the Prioritization of Embryos Deemed Suitable for Transfer: A Randomized Controlled Study
- Lead sponsor
- Alife Health
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 11, 2022
- Completion date
- December 20, 2024
- Enrollment
- 444 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.